CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection

Area of Science:

• Immunology
• Transplantation Biology
• Molecular Medicine

Background:

• Long-term lung transplant survival is limited by rapid allogeneic responses despite current immunosuppression.
• Allogeneic T cell activation and homing to secondary lymphoid tissues are critical barriers to graft survival.

Purpose of the Study:

• To investigate the role of the CCR4-ligand axis in T cell-mediated lung allograft rejection.
• To identify novel therapeutic targets for enhancing long-term lung transplant outcomes.

Main Methods:

• Utilized a stringent mouse model of allo-airway transplantation.
• Assessed the impact of CCR4 deficiency in recipient T cells on allograft injury.
• Evaluated the combination therapy of CCR4 blockade and CTLA4-Ig.

Main Results:

• The CCR4-ligand axis was identified as a key driver of allogeneic T cell homing and activation.
• CCR4 deficiency on T cells significantly reduced allograft injury.
• Combined CCR4 blockade and CTLA4-Ig achieved unprecedented long-term lung allograft accommodation.

Conclusions:

• CCR4-ligand interactions are central to allogeneic transplant rejection.
• Targeting CCR4 presents a promising strategy to improve long-term lung transplant survival.